Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer

This study has been completed.
Information provided by (Responsible Party):
NSABP Foundation Inc Identifier:
First received: August 19, 2011
Last updated: July 7, 2014
Last verified: July 2014